Alto Neuroscience (Series B)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Artificial Intelligence and Robotics
Funding URL
View Funding Page
Valuation
$175,000,000

Company Info
Founders
Amit Etkin
Company Description
Pioneering an approach to psychiatric drug development which matches the right patient with the right drug based on AI-derived brain biomarkers. Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Market
Information Technology
Coinvestors
Alkeon Capital,Apeiron Presight Capital Fund II,Harrison Metal,Apeiron Investment Group

Links
Back to Home Back to Artificial Intelligence and Robotics Deals View Funding Announcement